{"id":"W4310126163","doi":"10.1182/blood-2022-162738","title":"Elranatamab in Combination with Daratumumab for Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM): Results from the Phase 3 Magnetismm-5 Study Safety Lead-in Cohort","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University; Princess Margaret Cancer Centre","funders":"","keywords":"Daratumumab; Medicine; Multiple myeloma; Lenalidomide; Oncology; Internal medicine; Cohort; Refractory (planetary science); Materials science","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00229091,0.001047155,0.00152085,0.0003739683,0.0005244389,0.00112556,0.0006416405,0.0008103498,0.002382424],"category_scores_gemma":[0.001203133,0.0005011671,0.001862117,0.0004629015,0.0004025384,0.0006441679,0.0005219581,0.001994183,0.0007778877],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001165258,"about_ca_system_score_gemma":0.001711903,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001515981,"about_ca_topic_score_gemma":0.004455572,"domain_scores_codex":[0.9992852,0.0003248536,0.0000484486,0.000129939,0.0001139131,0.00009766961],"domain_scores_gemma":[0.9991795,0.0001037688,0.0002360844,0.00007957595,0.00007720809,0.0003238802],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6347368,0.04016282,0.09320074,0.0010395,0.00616987,0.0006360327,0.000632099,0.003375909,0.0326976,0.0002790003,0.01663199,0.1704376],"study_design_scores_gemma":[0.4165189,0.334116,0.2121532,0.00015048,0.006606571,0.001426816,0.0002150419,0.003147268,0.007275193,0.0004279057,0.01785476,0.0001079069],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9885126,0.00281835,0.000508067,0.0005531953,0.00008222973,0.00126529,0.004781648,0.00009646664,0.001382178],"genre_scores_gemma":[0.9836072,0.00180727,0.001485017,0.001213007,0.0001853753,0.0009876963,0.009330108,0.00003403764,0.001350336],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002382424,"threshold_uncertainty_score":0.0121156,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01625222232836121,"score_gpt":0.2780908681726396,"score_spread":0.2618386458442784,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}